These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8701030)

  • 41. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle.
    Brack KE; Jeffery SM; Lovick TA
    Eur J Neurosci; 2006 Jun; 23(12):3309-18. PubMed ID: 16820020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
    Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the role of cholecystokinin in the mediation of spinal reflex excitability in intact and axotomized rats.
    Lucas GA; Xu XJ; Wiesenfeld-Hallin Z
    Neuropeptides; 1998 Feb; 32(1):73-8. PubMed ID: 9571648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of biologic gastrin activity of compound CI-988 in the isolated, vascularly perfused rat stomach.
    Marvik R; Sandvik AK; Waldum HL
    Scand J Gastroenterol; 1997 Jun; 32(6):519-22. PubMed ID: 9200280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
    Patel S; Chapman KL; Smith AJ; Bailey I; Freedman SB
    Regul Pept; 1996 Aug; 65(1):29-35. PubMed ID: 8876033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin.
    Smith AJ; Freedman SB
    Life Sci; 1996; 58(11):883-95. PubMed ID: 8786694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep.
    Ebenezer IS; Parrott RF
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):235-8. PubMed ID: 8803955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D; Smith GP
    Physiol Behav; 1998 Aug; 65(1):11-4. PubMed ID: 9811359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL; Liberzon I
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II.
    Takeda Y; Kawagoe K; Yokomizo A; Yokomizo Y; Hosokami T; Shimoto Y; Tabuchi Y; Ogihara Y; Otsubo R; Honda Y; Yokohama S
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):951-61. PubMed ID: 9658573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats.
    Doong ML; Lu CC; Kau MM; Tsai SC; Chiao YC; Chen JJ; Yeh JY; Lin H; Huang SW; Chen TS; Chang FY; Wang PS
    Br J Pharmacol; 1998 Jul; 124(6):1123-30. PubMed ID: 9720782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a functional role of cholecystokinin receptors in the rat thyroid gland.
    Ginda WJ
    Folia Histochem Cytobiol; 2001; 39(4):331-4. PubMed ID: 11766768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
    Léna I; Roques BP; Durieux C
    J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
    Lemaire M; Böhme GA; Piot O; Roques BP; Blanchard JC
    Psychopharmacology (Berl); 1994 Aug; 115(4):435-40. PubMed ID: 7871086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
    Stephens DN; Shearman GT; Kehr W
    Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
    Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.
    Singh L; Oles RJ; Field MJ; Atwal P; Woodruff GN; Hunter JC
    Br J Pharmacol; 1996 Jul; 118(5):1317-25. PubMed ID: 8818359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.
    Wilson J; Watson WP; Little HJ
    Psychopharmacology (Berl); 1998 May; 137(2):120-31. PubMed ID: 9629998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.